Revvity (RVTY): analysis and statistics
Return, volatility, Sharpe ratio and risk for Revvity, a component of the S&P 500 in the Health Care. Data as of 2026-10-29.
| Last close price | $165.33 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +19.50% |
| Total return over period | +70.18% |
| Annualized volatility | 36.62% |
| Period volatility | 63.25% |
| Period T-bill | 12.40% |
| Sharpe ratio | 0.91 |
| Sortino ratio | 1.34 |
| Max drawdown | -35.30% |
| CVaR 95% (avg. loss, worst 5% of days) | -5.00% |
| Correlation with the S&P 500 | 0.43 |
| Period range | $81.47 – $165.33 |
| Trading days analyzed | 752 |
Over the last 3.0 years, Revvity (RVTY) has posted an annualized return of +19.50% with annual volatility of 36.62%, a Sharpe ratio of 0.91. Its worst stretch (max drawdown from a peak) was -35.30%. Its correlation with the S&P 500 is 0.43, which means it moves moderately in step with the index.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how RVTY would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with RVTY →
Other Health Care stocks
Is it part of the S&P 500?
Yes, Revvity (RVTY) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio